DelMar Pharmaceuticals Inc (NASDAQ:DMPI) investors cheer the news that the company was awarded a US patent for improved analytical methods for analyzing and …
In a research note published this morning, Maxim Group analyst Jason Kolbert reaffirmed a Buy rating on DelMar Pharmaceuticals (NASDAQ: DMPI) with an …
